Business
Easton Pharmaceuticals Releases Preliminary Vaporizer Related Sales of $25,638.00 in the Month of November
Easton Pharmaceuticals Releases Preliminary Vaporizer Related Sales of $25,638.00 in the Month of November.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Releases Preliminary Vaporizer Related Sales of $25,638.00 in the Month of November\n \n \nEaston Pharmaceuticals Releases Preliminary Vaporizer Related Sales of $25,638.00 in the Month of November\n \n NEW YORK, NY--(Marketwired - Dec 15, 2014) - Easton Pharmaceuticals (OTC PINK: EAPH) Is pleased to announce details on its Vaporizer units progress with sales of $25,638.00 for the month of November. \n Month end inventory on hand was shown at $10,670.00 for its vaporizer unit. Vaporizers were not Easton's primary goal when it entered into the Medical Marijuana Industry. However, the company has been able to leverage its vaporizer unit to negotiate with Legal Marijuana Prescription Services Businesses.\n Its first sale of a Vaporizer was made on the first day of its website launch and was for a ZEDS vaporizer unit. Since that date sales have been progressing at a steady pace, Cyber week provided an additional catalyst for sales in November. Currently the most popular brands have been the following units:\n http://ecigmarkets.com/product/hebe-2-0/\n The HEBE 2.0 is a robust vaporizing instrument featuring an intuitive temperature control system. It offers a wide-mouth heating chamber for easy loading and cleaning and features a durable and rugged rubberized exterior.\n http://ecigmarkets.com/product/davinci-vaporizer/\n The DaVinci Vaporizer combines a feature rich platform with rugged portability. Our most popular model in the DaVinci line, which is offered in a very appealing and popular black matte finish.\n The company believes it has already received a good return on its conservative investments made on its vaporizer Initiative. Future sales cannot be accurately estimated but testing has shown that Vaporizer retail Location(s) in the Greater Toronto Area along with a New York City location would both be viable initiatives. The company believes utilizing these retail locations as multi purpose facilities in the selling of products and services such as Vaporizers, OTC products, and a Marijuana Prescription Service would be successful. This could lead towards its ultimate goal of acquiring a database of Legal Canadian Medical Marijuana patients which the company has initiated discussion on. Monetizing of these patients could be made in two ways which would include sub...